Stockscreener 앱 받기
8.1792
1.93%
-0.1208
전일 마감가:
$8.30
열려 있는:
$8.23
하루 거래량:
95,280
Relative Volume:
0.32
시가총액:
$174.52M
수익:
-
순이익/손실:
$-52.07M
주가수익비율:
-39.38
EPS:
-0.2077
순현금흐름:
$-44.93M
1주 성능:
-10.45%
1개월 성능:
-16.68%
6개월 성능:
-18.95%
1년 성능:
-38.41%
1일 변동 폭
$8.10
$8.43
1주일 범위
$7.8001
$9.16
52주 변동 폭
$6.50
$19.85
Cybin Inc Stock (CYBN) Company Profile
명칭
Cybin Inc
전화
908 764 8385
주소
100 King Street West, Suite 5600, Toronto
CYBN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYBN
Cybin Inc
|
8.12 | 174.52M | 0 | -52.07M | -44.93M | -0.2077 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.52 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
697.34 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
617.89 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
269.10 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Cybin Inc Stock (CYBN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-11-19 | 다운그레이드 | Maxim Group | Buy → Hold |
Cybin Inc 주식(CYBN)의 최신 뉴스
Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - MSN
How to Take Advantage of moves in (CYBN) - Stock Traders Daily
Cybin (OTCMKTS:CLXPF) Stock Price Down 2.5%Should You Sell? - MarketBeat
Revolutionizing Mental Health Through Psychedelic Therapeutics | by Dr. Gleb Tsipursky | Feb, 2025 - DataDrivenInvestor
Cybin (NYSE:CYBN) Price Target Cut to $150.00 by Analysts at HC Wainwright - MarketBeat
Cybin (OTCMKTS:CYBN) Trading Up 1.2%Here's Why - MarketBeat
Canaccord cuts Cybin stock target to $73, maintains Buy rating - MSN
Cybin (NYSE:CYBN) Price Target Lowered to $73.00 at Canaccord Genuity Group - MarketBeat
Cybin stock price target cut to $150 at H.C. Wainwright - MSN
Cybin stock price target cut to $150 at H.C. Wainwright By Investing.com - Investing.com Australia
Canaccord cuts Cybin stock target to $73, maintains Buy rating By Investing.com - Investing.com Nigeria
(CYBN) Investment Analysis - Stock Traders Daily
Cybin sees third-quarter loss on R&D costs, advances clinical programs - Green Market Report
Cybin Accelerates PARADIGM Program for Depression Treatment - TipRanks
Cybin's Depression Drug Shows Perfect Response Rate, Advances to Pivotal Phase 3 with C$136M War Chest - StockTitan
Upstart (UPST) Reports Earnings Tomorrow: What To Expect - The Globe and Mail
Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
Trade thoughts for Gold futures - The Globe and Mail
Is Rigetti Computing a Millionaire-Maker Stock? - The Globe and Mail
HC Wainwright Forecasts Cybin's Q3 Earnings (NYSE:CYBN) - MarketBeat
What is HC Wainwright's Estimate for Cybin FY2029 Earnings? - MarketBeat
Cybin (OTCMKTS:CLXPF) Shares Up 1.9%What's Next? - MarketBeat
What is HC Wainwright's Forecast for Cybin FY2029 Earnings? - MarketBeat
How To Trade (CYBN) - Stock Traders Daily
HC Wainwright Issues Optimistic Estimate for Cybin Earnings - Defense World
Wall Street Analysts Believe Cybin Inc. (CYBN) Could Rally 952.23%: Here's is How to Trade - Yahoo Finance
HC Wainwright Has Bearish Outlook for Cybin FY2029 Earnings - Defense World
H.C. Wainwright maintains $190 target on Cybin Inc. shares - MSN
H.C. Wainwright maintains $190 target on Cybin Inc. shares By Investing.com - Investing.com South Africa
HC Wainwright Reiterates "Buy" Rating for Cybin (NYSE:CYBN) - MarketBeat
Cybin (OTCMKTS:CYBN) Shares Up 1.8%Should You Buy? - MarketBeat
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
(CYBN) Trading Signals - Stock Traders Daily
Cybin Inc (CYBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.35%
0.90%
자본화:
|
볼륨(24시간):